Skip to main content
Book Chapter

Antimetabolic Anticancer Drugs

  • Kim K
  • Roh J
  • Wee H
  • et al.
Springer Netherlands, (2016), 95-112
DOI: 10.1007/978-94-024-0844-7_5
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Antimetabolic drugs bind to a specific enzyme and prevent normal metabolites from interacting with the enzymes, leading to inhibition of a specific metabolic pathway. Especially, the antimetabolic anticancer drugs interfere with DNA synthesis at multiple levels by...

Cite

CITATION STYLE

APA

Kim, K.-W., Roh, J. K., Wee, H.-J., & Kim, C. (2016). Antimetabolic Anticancer Drugs. In Cancer Drug Discovery (pp. 95–112). Springer Netherlands. https://doi.org/10.1007/978-94-024-0844-7_5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free